Skip to content

Improving HIV Prevention and Substance Use Post-Sexual Assault Services

Improving HIV Prevention and Substance Use Post-Sexual Assault Services for Adolescents and Young Adults

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07225062
Enrollment
90
Registered
2025-11-05
Start date
2027-01-04
Completion date
2027-06-30
Last updated
2025-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections, Substance Use, Sexual Assault

Brief summary

The purpose of this study is to tailor existing sexual assault nurse examiner (SANE) services with same-day HIV prophylaxis and substance use screening, brief intervention, or referral using semi-structured adolescents and young adults (AYA) survivor and key informant interviews, and iterative co-design/pilot testing of adapted strategies with the youth working group (YWG), to optimize study mechanisms and outcome measures using cognitive interviews, analysis of community partner data, and recruitment and retention strategies with the youth working group (YWG) and community advisory board (CAB), to conduct a pilot randomized controlled trial with 40 AYA to test feasibility, acceptability, and initial efficacy compared to usual care, to evaluate recruitment, randomization, and follow-up strategies; adherence to intervention dose; retention benchmarks; and acceptability and to evaluate preliminary efficacy of outcome measures (uptake of post-assault HIV prevention and substance use treatment).

Interventions

The intervention has three components: 1). Exploring how to increase access to and promotion of SANE services among vulnerable AYA within the 72 hr window for nPEP treatment; 2). Enhanced SANE services to increase same-day access to nPEP and DoxyPEP and 3). An advocate-delivered screening, brief intervention, and referral to prevent and address substance misuse.

BEHAVIORALUsual Care

The usual care condition will be used with control participants and entail receiving typical SANE services without modifications to enhance HIV prevention or substance use screening, brief intervention, or referral to treatment

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Data collectors will be blinded

Eligibility

Sex/Gender
ALL
Age
17 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* experienced a sexual assault within the last 72 hours * speak English * not planning to move out of the metro area during the study.

Exclusion criteria

* noticeably intoxicated or under the influence * are overtly having severe, untreated mental illness symptoms

Design outcomes

Primary

MeasureTime frameDescription
Acceptability as measured by score on the credibility/expectancy questionnaireend of study (1 month after baseline)The Credibility and Expectancy Questionnaire (CEQ) was used to assess the acceptability of the intervention. All participants completed both subscales: the credibility subscale and the expectancy subscale. Each subscale total score ranges from 0 to 10, with higher scores indicating greater perceived acceptability. The expectancy subscale is reported.
Retention as measured by the number of participants that completed the one month follow-up surveyend of study (1 month after baseline)
Retention of the intervention group as measured by the number of participants that completed the one month follow-up surveyend of study (1 month after baseline)
Retention of the control group as measured by the number of participants that completed the one month follow-up surveyend of study (1 month after baseline)
Adherence to intervention as measured by percentage of content completed in the fidelity checklistend of study (1 month after baseline)
Acceptability as measured by percentage of data lossend of study (1 month after baseline)
Recruitment feasibility as measured by percentage of eligible individuals screenedend of study (1 month after baseline)
Recruitment feasibility as measured by percentage of eligible individuals enrolledend of study (1 month after baseline)
Recruitment feasibility as measured by time delay from screening to enrollmentend of study (1 month after baseline)
Recruitment feasibility as measured by time to enroll sufficient sample sizeend of study (1 month after baseline)
Recruitment feasibility as measured by percentage loss to exclusion criteria.end of study (1 month after baseline)
Randomization strategies as measured by proportion randomized to intervention and controlend of study (1 month after baseline)

Secondary

MeasureTime frame
Uptake of substance use treatment as self reported as reported on the self report questionnaire1-month follow-up
Uptake of post-assault HIV prevention as measured by self report of Doxycycline Post-Exposure Prophylaxis (DoxyPEP) uptake1-month follow-up
Adherence of non-occupational Post-Exposure Prophylaxis (nPEP) as reported on the self report questionnaire1-month follow-up
Adherence of substance use treatment as reported on the self report questionnaire1-month follow-up
Uptake of post-assault HIV prevention as measured by self report of nPEP uptake1-month follow-up

Countries

United States

Contacts

Primary ContactDiane M Santa Maria, DrPH,MSN,FAANRN,PHNA-BC,FSAHM
Diane.M.SantaMaria@uth.tmc.edu(713) 500-2002
Backup ContactJennifer T Jones
Jennifer.D.Torres@uth.tmc.edu713-500-9928

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026